National Cancer Institute
Found 605 results for your search:
Total relevant funding to Ovarian Cancer for this search:
$109,786,028
Fiscal Year FY 2017
Cancer Type [Ovarian Cancer]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 605 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership 2U54CA163071-06 $1,427,230 $71,362 MATTA, JAIME PONCE SCHOOL OF MEDICINE
2
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers 5R01CA184968-04 $509,161 $509,161 SIKIC, BRANIMIR STANFORD UNIVERSITY
3
(PQD5) Avatar-directed Treatment for Ovarian Cancer 5R01CA184502-04 $714,297 $714,297 WEROHA, SARAVUT MAYO CLINIC ROCHESTER
4
0021.0001 CG 425 METAVIVOR 261200800001E $319,219,481 $264,206 UNKNOWN, UNKNOWN LEIDOS BIOMEDICAL RESEARCH, INC.
5
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership 2U54CA163068-06 $1,656,304 $82,815 MUNOZ-ANTONIA, TERESITA H. LEE MOFFITT CANCER CTR & RES INST
6
402 -- CHEMOPREVENTION OF COLORECTAL CANCER . CONTRACTOR: UNIVERSITY OF OKLAHOMA, HEALTH SCIENCES CENTER, DUNS: 878648294. CONTRACT NO: HHSN261500038I, TASK ORDER HHSN26100011. FROM 9/15/17 TO 9/14/ 261201500038I $1,236,052 $1,236,052 UNKNOWN, UNKNOWN UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
7
A Follow-up Study for Causes of Cancer in Black Women 2U01CA164974-07 $2,195,369 $219,537 ROSENBERG, LYNN BOSTON UNIVERSITY MEDICAL CAMPUS
8
A Follow-up Study for Causes of Cancer in Black Women 5UM1CA164974-06 $639,740 $63,974 ROSENBERG, LYNN BOSTON UNIVERSITY MEDICAL CAMPUS
9
A Multimodal Imaging Strategy for Preclinical Optimization of Anticancer Nanomedicines 5F31CA203476-02 $34,742 $34,742 RADFORD, DAVID UNIVERSITY OF UTAH
10
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer 5R01CA175318-03 $354,563 $354,563 HATEFI, ARASH RUTGERS, THE STATE UNIV OF N.J.
11
A network platform to connect drug response and prognosis phenotypes for cancers 5R01CA196631-02 $395,911 $197,956 LI, HU MAYO CLINIC ROCHESTER
12
A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery 1R03CA216127-01 $77,000 $77,000 YANG, YANG YALE UNIVERSITY
13
A Novel Agent for Ovarian Cancer 1R43CA221477-01 $300,000 $300,000 XIE, GANG MEDICON, INC.
14
A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer 5R00CA166228-05 $249,000 $249,000 GATZA, MICHAEL RBHS -CANCER INSTITUTE OF NEW JERSEY
15
A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy 5R44CA206606-02 $1,004,186 $1,004,186 WINRAM, SCOTT CYNVEC, LLC
16
A Systems Biology Approach to Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer 1F30CA213737-01 $44,244 $44,244 MCGEHEE, CORDELIA MAYO CLINIC ROCHESTER
17
A Target-Directed Reagent Pipeline via Microfluidic mRNA Display 1R21CA204708-01A1 $227,675 $113,838 MALMSTADT, NOAH UNIVERSITY OF SOUTHERN CALIFORNIA
18
AARP prospective study of diet and cancer ZIA CP010196-03152 $703,174 $35,159 Sinha, Rashmi DCEG (NCI)
19
Abramson Cancer Center Support Grant 3P30CA016520-41S1 $125,000 $3,750 DANG, CHI UNIVERSITY OF PENNSYLVANIA
20
Abramson Cancer Center Support Grant 3P30CA016520-41S2 $62,491 $1,875 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
21
Abramson Cancer Center Support Grant 5P30CA016520-41 $7,810,244 $234,307 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
22
Activatable molecular cancer imaging probe ZIA BC 011512 $256,560 $25,656 Kobayashi, Hisataka CCR (NCI)
23
Activating Cell Death Pathways in Breast Cancer Cells ZIA SC 007263 $524,596 $52,460 Lipkowitz, Stanley CCR (NCI)
24
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research 5U24CA180921-05 $705,863 $141,173 BECICH, MICHAEL UNIVERSITY OF PITTSBURGH AT PITTSBURGH
25
Algorithms for Literature-Guided Multi-Platform Identification of Cancer Subtypes 5R21CA209848-02 $162,581 $162,581 CHUNG, DONGJUN MEDICAL UNIVERSITY OF SOUTH CAROLINA
26
Ambient dioxin exposure and cancer risk in women (IWHS and AHS) ZIA CP010125-10712 $56,170 $5,617 Jones, Rena DCEG (NCI)
27
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer 5R01CA182832-04 $323,044 $323,044 MATEI, DANIELA NORTHWESTERN UNIVERSITY AT CHICAGO
28
An in vivo model for CCNE1 amplified tumorigenesis 1F32CA221093-01 $60,990 $60,990 KROEGER, PAUL UNIVERSITY OF PENNSYLVANIA
29
Analysis of BRCA Testing Patterns Using the Utah Population Database 1R03CA212911-01 $75,834 $37,917 KOHLMANN, WENDY UNIVERSITY OF UTAH
30
Analysis of BRCA1 Recombination Functions 5R01CA095175-13 $328,700 $164,350 SCULLY, RALPH BETH ISRAEL DEACONESS MEDICAL CENTER
31
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells 5R01CA181543-04 $395,654 $395,654 BRUGGE, JOAN HARVARD MEDICAL SCHOOL
32
Anatomic Pathology Residency Program ZIE BC 011384 $1,094,457 $21,889 Barr, Frederic CCR (NCI)
33
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca 5R01CA172667-05 $334,984 $334,984 NOMURA, DANIEL UNIVERSITY OF CALIFORNIA BERKELEY
34
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID ZIA SC 004020 $2,592,300 $259,230 Berzofsky, Jay CCR (NCI)
35
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer 3R01CA135354-07S1 $99,082 $99,082 BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR
36
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer 5R01CA135354-07 $380,000 $380,000 BAST, ROBERT UNIVERSITY OF TX MD ANDERSON CAN CTR
37
Assessment of Screening Modalities for Gynecologic Cancers ZIA CP010126-10495 $126 $63 Wentzensen, Nicolas DCEG (NCI)
38
Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute 5R50CA211108-02 $250,131 $125,066 MINDERMAN, HANS ROSWELL PARK CANCER INSTITUTE CORP
39
Averting recurrent and resistant ovarian tumors 1R01CA211175-01 $454,502 $454,502 WANG, QIEN OHIO STATE UNIVERSITY
40
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research ZIG BC 010856 $14,497,944 $724,898 Custer, Mary CCR (NCI)
41
Baylor College of Medicine Cancer Center 3P30CA125123-11S1 $118,333 $2,367 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
42
Baylor College of Medicine Cancer Center 3P30CA125123-11S2 $118,875 $2,378 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
43
Baylor College of Medicine Cancer Center 3P30CA125123-11S3 $122,250 $2,445 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
44
Baylor College of Medicine Cancer Center 3P30CA125123-11S4 $250,002 $5,000 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
45
Baylor College of Medicine Cancer Center 5P30CA125123-11 $3,253,119 $65,062 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
46
BCDDP: Breast cancer detection demonstration project followup study - I ZIA CP010182-01030 $41,204 $8,241 Schairer, Catherine DCEG (NCI)
47
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance 5R01CA193249-02 $621,318 $621,318 LUTGENDORF, SUSAN UNIVERSITY OF IOWA
48
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins ZIA BC 010030 $755,842 $37,792 Ambudkar, Suresh CCR (NCI)
49
Biomedical Applications of Expanded Porphyrins: Development of Gold-Texaphyrin Conjugates 2R01CA068682-25 $360,416 $360,416 SESSLER, JONATHAN UNIVERSITY OF TEXAS, AUSTIN
50
Blocking NK cell shedding of CD16a to increase cancer cell killing 5R01CA203348-02 $444,991 $444,991 WALCHECK, BRUCE UNIVERSITY OF MINNESOTA
Total relevant funding to Ovarian Cancer for this search: $109,786,028
Showing 1 - 50 of 605 results
Go to top